Neuroimaging techniques aimed at studying structural changes of the brain m
ay provide useful information for the diagnosis and the clinical management
of patients with dementia. Magnetic resonance imaging (MRI) may show abnor
malities amenable to surgical treatment in a significant percentage of pati
ents with cognitive impairment. MRI may also assist the differential diagno
sis in dementia associated with metabolic or inflammatory diseases.
MRI has the potential to detect focal signal abnormalities which may assist
the clinical differentiation between Alzheimer's disease (AD) and vascular
dementia (VaD). Severe temporal atrophy, hyperintensities involving the hi
ppocampal or insular cortex, and gyral hyperntense bands are more frequentl
y noted in AD. Basal ganglionic/thalamic hyperintense foci, thromboembolic
infarctions, confluent white matter and irregular periventricular hyperinte
nsities are more common in VaD.
The high sensitivity of MRI in detecting T2 hyperintense lesions and the lo
w specificity of white matter lesions have resulted in a poor correlation b
etween MRI findings and both neuropathological and clinical manifestations.
In particular, MRI has disclosed a series of white matter focal changes in
the elderly population, which are not necessarily associated with cognitiv
e dysfunction.
The recent advent of a new MRI method sensitive to the microstructural chan
ges of white matter, the so-called diffusion tensor imaging, may be helpful
in correlating clinical manifestations with white matter abnormalities.